Robinson Brothers will be represented by members from the commercial, procurement and research & development team.
As a regular exhibitor, Robinson Brothers is looking forward to this year’s schedule, which entails numerous presentations showcasing product and service developments in chemical manufacturing.
Robinson Brothers’ expertise in the pharmaceutical market began in the 1940s, when the company manufactured Sulfapyridine; a sulfonamide antibiotic often referred to as M&B 956. Through exploring new technologies, its strengths have continued to grow.
The company’s research & development division has always kept a sharp focus on process development and optimisation techniques, along with continuously aiming to provide solutions to suit customer demands and market requests.
Robinson Brothers’ core competences include the following:
- hydrogenation
- chlorosulfonation
- oxidation
- thiolation
- bromination
- methylation
- heterocyclic chemistry
- carbon disulfide chemistry
- dehydrogenation.
Its confidence in handling challenging reagents and investigating methods for process efficiency has led to Robinson Brothers becoming a key member in the pharmaceutical supply chain.
The company is committed in providing quality ingredients that satisfy regulatory requirements and protect Intellectual Property where required.
Robinson Brothers is an ISO 9001:2008 compliant and FDA audited site.
With the capacity to offer a small scale sample for validation, right through to supplying multi-tonne quantities, Robinson Brothers has become a chemical manufacturer of choice providing excellence in chemistry since 1869.
Meet Robinson Brothers at CPhI WW 2017; Stand 102F81 / Hall 10.2.
